Catalyst
Slingshot members are tracking this event:
Tracon (TCON) Presents Phase 2 Data Evaluating TRC105 in Recurrent Glioblastoma (GBM)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TCON |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 10, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Trc105, Recurrent Glioblastoma
